Index RUT
P/E 135.91
EPS (ttm) 0.07
Insider Own 11.33%
Shs Outstand 21.23M
Perf Week 1.55%
Market Cap 194.77M
Forward P/E 33.61
EPS next Y 0.27
Insider Trans -1.47%
Shs Float 18.85M
Perf Month 1.10%
Income 1.48M
PEG 4.53
EPS next Q 0.07
Inst Own 71.99%
Short Float 0.87%
Perf Quarter 41.58%
Sales 132.78M
P/S 1.47
EPS this Y 256.25%
Inst Trans -4.50%
Short Ratio 1.89
Perf Half Y 33.53%
Book/sh 2.61
P/B 3.50
EPS next Y 91.23%
ROA 1.43%
Short Interest 0.16M
Perf Year -10.98%
Cash/sh 0.02
P/C 512.55
EPS next 5Y 30.00%
ROE 2.77%
52W Range 5.74 - 10.99
Perf YTD -13.09%
Dividend Est. -
P/FCF 12.18
EPS past 5Y -
ROI 1.68%
52W High -16.65%
Beta 1.53
Dividend TTM -
Quick Ratio 1.59
Sales past 5Y 13.56%
Gross Margin 49.86%
52W Low 59.72%
ATR (14) 0.41
Dividend Ex-Date -
Current Ratio 1.98
EPS Y/Y TTM 61.63%
Oper. Margin 4.16%
RSI (14) 61.13
Volatility 4.71% 4.81%
Employees 516
Debt/Eq 0.59
Sales Y/Y TTM 8.09%
Profit Margin 1.12%
Recom 1.00
Target Price 14.12
Option/Short Yes / Yes
LT Debt/Eq 0.59
EPS Q/Q 163.09%
Payout 0.00%
Rel Volume 0.68
Prev Close 9.05
Sales Surprise 2.45%
EPS Surprise 28.00%
Sales Q/Q 10.69%
Earnings Nov 07 BMO
Avg Volume 86.88K
Price 9.16
SMA20 1.58%
SMA50 17.91%
SMA200 24.39%
Trades
Volume 58,731
Change 1.22%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-26-24 Initiated
B. Riley Securities
Buy
$13
Apr-26-21 Initiated
Northland Capital
Outperform
$27
Dec-29-20 Initiated
Sidoti
Buy
$26
Aug-31-20 Initiated
Craig Hallum
Buy
$28
Jun-09-20 Initiated
Lake Street
Buy
$17
Dec-03-24 08:30AM
Nov-22-24 06:30AM
Nov-18-24 09:15AM
Nov-08-24 02:50AM
(Thomson Reuters StreetEvents) +6.40%
02:15AM
06:30AM
Loading…
Nov-07-24 06:30AM
Nov-06-24 07:48AM
Oct-31-24 06:30AM
Oct-09-24 05:42PM
Oct-04-24 06:05AM
Sep-27-24 06:30AM
Sep-11-24 06:30AM
06:30AM
Sep-04-24 06:30AM
Aug-08-24 06:30AM
06:30AM
Loading…
Aug-06-24 06:30AM
Aug-02-24 04:30PM
Jul-17-24 06:15PM
Jun-11-24 10:50AM
Jun-04-24 04:30PM
May-20-24 05:10PM
04:30PM
May-13-24 11:42AM
May-09-24 06:30AM
May-02-24 04:30PM
Apr-03-24 06:30AM
Mar-15-24 03:07PM
Mar-14-24 10:10PM
(Thomson Reuters StreetEvents) -5.25%
07:51AM
06:30AM
06:30AM
Loading…
Mar-08-24 06:30AM
Dec-05-23 10:25AM
Nov-28-23 04:30PM
Nov-09-23 04:15PM
Nov-08-23 03:12PM
Nov-07-23 11:27PM
(Thomson Reuters StreetEvents)
06:59AM
06:30AM
Oct-31-23 06:30AM
Sep-05-23 06:30AM
Aug-03-23 06:30AM
Jul-27-23 06:30AM
Jun-21-23 06:30AM
May-09-23 07:15AM
May-05-23 04:30PM
May-04-23 06:30AM
Apr-27-23 04:30PM
Apr-25-23 04:30PM
Mar-19-23 09:37PM
Mar-15-23 11:03PM
(Thomson Reuters StreetEvents) -13.80%
06:30AM
Mar-13-23 04:30PM
Nov-10-22 04:15PM
Nov-08-22 06:30AM
Nov-03-22 09:15AM
06:30AM
Nov-02-22 04:30PM
Sep-23-22 04:05PM
Sep-07-22 04:05PM
Aug-04-22 06:30AM
Jul-29-22 04:05PM
Jun-14-22 06:33AM
May-26-22 06:35AM
May-05-22 06:35AM
Apr-28-22 04:10PM
04:05PM
Feb-22-22 06:30AM
Feb-10-22 06:00AM
Feb-09-22 04:30PM
Jan-18-22 07:30AM
Jan-13-22 06:30AM
Nov-15-21 06:33AM
Nov-04-21 03:01PM
Nov-03-21 04:33PM
Nov-02-21 06:33AM
Sep-08-21 05:12PM
Aug-12-21 07:45AM
06:30AM
Aug-05-21 03:01PM
06:30AM
Jul-01-21 04:21AM
Jun-30-21 06:33AM
Jun-29-21 06:30AM
May-27-21 06:30AM
May-06-21 06:31AM
Apr-29-21 04:10PM
Apr-21-21 06:31AM
Apr-12-21 04:00AM
Mar-23-21 07:30PM
Mar-22-21 05:30PM
Mar-17-21 07:15AM
06:30AM
Mar-13-21 02:50AM
Mar-08-21 06:30AM
Mar-03-21 03:54PM
(Investor's Business Daily)
Mar-02-21 06:30AM
Feb-15-21 01:16AM
Feb-11-21 06:30AM
Feb-03-21 06:31AM
Feb-01-21 11:27AM
(Investor's Business Daily)
InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Patient Services and Device Solutions segments. The Patient Services segment involves the durable medical equipment, clinic-to-home health care, logistics and billing, and oncology business. The Device Solutions segment includes the sale or rent of new and pre-owned pole-mounted and ambulatory infusion pumps, treatment-related consumables, biomedical recertification, maintenance and repair services for oncology practices. The company was founded by Steven E. Watkins in August 2005 and headquartered in Rochester Hills, MI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Dilorio Richard Chief Executive Officer Nov 25 '24 Sale 9.32 20,000 186,416 436,659 Nov 27 06:24 PM Dilorio Richard Chief Executive Officer Nov 26 '24 Sale 8.91 14,602 130,165 422,057 Nov 27 06:24 PM Dilorio Richard Chief Executive Officer Nov 27 '24 Sale 8.87 5,398 47,885 416,659 Nov 27 06:24 PM Richard Dilorio Director Nov 25 '24 Proposed Sale 9.33 40,000 373,200 Nov 25 04:40 PM Chupa Addam Executive VP and CIO Oct 31 '24 Option Exercise 0.00 20,000 0 45,915 Nov 04 07:31 PM Funke Jerod EVP-Chief HR Officer Oct 09 '24 Option Exercise 0.00 12,500 0 13,500 Oct 11 07:35 PM Eichenbaum Kenneth D. Director Sep 23 '24 Buy 5.89 4,000 23,560 4,000 Sep 25 06:19 PM Dilorio Richard Chief Executive Officer Jun 26 '24 Option Exercise 2.69 50,000 134,500 490,121 Jun 28 06:41 PM BOYD RALPH F JR Director May 23 '24 Buy 7.13 4,000 28,520 6,000 May 23 06:07 PM HUSS BEVERLY A Director May 22 '24 Buy 6.86 4,300 29,486 4,300 May 23 06:03 PM Steele Barry G Executive VP and CFO May 18 '24 Option Exercise 0.00 7,051 0 70,481 May 21 06:24 PM Steele Barry G Executive VP and CFO May 20 '24 Buy 6.47 3,000 19,398 70,195 May 21 06:24 PM Dilorio Richard Chief Executive Officer May 18 '24 Option Exercise 0.00 14,103 0 446,940 May 21 06:22 PM Lachance Carrie President and COO May 18 '24 Option Exercise 0.00 8,077 0 186,567 May 21 06:19 PM Funke Jerod EVP-Chief HR Officer May 20 '24 Buy 6.39 1,000 6,388 1,000 May 21 06:17 PM Chupa Addam Executive VP and CIO May 21 '24 Buy 6.67 1,000 6,670 24,774 May 21 06:14 PM GENDRON PAUL ANDREW Director May 20 '24 Buy 6.54 5,000 32,700 65,000 May 21 06:09 PM Shuda Scott Director May 14 '24 Option Exercise 4.70 35,000 164,500 125,494 May 16 07:23 PM Lachance Carrie President and COO Mar 01 '24 Option Exercise 0.00 50,000 0 193,745 Mar 05 08:00 PM Chupa Addam Executive VP and CIO Feb 09 '24 Option Exercise 0.00 3,000 0 22,393 Feb 13 08:51 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite